Fubotv earnings beat by $0.10, revenue topped estimates
Carolyn Shelton, the Senior Vice President of Quality and Regulatory at Nexalin Technology , Inc. (NASDAQ:NXL), recently acquired 6,000 shares of the company’s common stock. The purchase, executed on March 12, 2025, was made at a price of $2.20 per share, totaling $13,200. The transaction comes as the stock shows significant volatility, having delivered an impressive 400% return over the past year, according to InvestingPro data. Following this transaction, Shelton’s total holdings, including shares owned directly and indirectly, amount to 30,000 shares. The acquisition reflects Shelton’s ongoing investment in the company, as noted in the latest SEC filing. InvestingPro analysis indicates the company maintains a strong balance sheet with cash exceeding debt, though it currently trades above its Fair Value. Discover 8 additional exclusive insights and real-time valuations with InvestingPro.
In other recent news, Nexalin Technology, Inc. announced a significant development with the effectiveness of its Registration Statement, as filed with the Securities and Exchange Commission. This statement involves up to 2,798,613 shares of the company’s common stock, including 347,250 shares potentially issuable upon the exercise of warrants granted to Maxim Partners, LLC. Additionally, up to 2,315,000 shares are covered, issuable upon the exercise of warrants distributed to investors who participated in the company’s 2022 public offering. Investors holding these warrants have the opportunity to exercise them at a price of $4.15 per share. The company’s common stock and warrants are traded on The Nasdaq Stock Market. This development reflects Nexalin Technology’s commitment to transparency and regulatory compliance. The Registration Statement is a crucial step following the company’s initial public offering in 2022. Nexalin Technology’s CEO, Mark White, confirmed the company’s adherence to the Securities Exchange Act of 1934.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.